Stock Information | Gentian Share | Corporate Reporting
medical, diagnostics, immunoassays, assays, in vitro diagnostics, IVD products, avian antibodies, antibodies, clinical chemistry, diagnostic tests, biotechnology
15618
page-template,page-template-full_width,page-template-full_width-php,page,page-id-15618,page-child,parent-pageid-15340,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-14.2,qode-theme-bridge,wpb-js-composer js-comp-ver-6.0.5,vc_responsive
 

The Gentian Share

The Gentian Share

Find stock information and news about Gentian Diagnostics AS and the Gentian share at Oslo Børs where you find us under the ticker GENT-ME.

Shareholder structure

20 largest shareholders in Gentian Diagnostics AS as of 28.06.2019 according to VPS

ShareholderNo of Shares%
Holta Life Sciences AS 2 014 70213,09 %
Vatne Equity AS 1 910 34012,41 %
Safrino AS 1 300 0008,44 %
Salix AS 1 132 0407,35 %
Norron Sicav - Target 617 5004,01 %
Vingulmork Predictor AS 535 7103,48 %
Storebrand Vekst 493 8643,21 %
Norda ASA 455 0822,96 %
Portia AS 425 0002,76 %
Statoil Pensjon 392 6902,55 %
Verdipapirfondet DNB SMB 376 6302,45 %
Silvercoin Industries AS 330 8092,15 %
Bård Sundrehagen 307 0101,99 %
Cressida AS 235 0001,53 %
Marstal AS 202 5001,32 %
Strawberry Capital AS 200 3001,30 %
Spar Kapital Investor AS 192 2911,25 %
Mutus AS 187 2101,22 %
OM Holding AS 179 0001,16 %
Lioness AS 150 0000,97 %
Other Shareholders 3 758 24324,41 %
Total Shares 15 395 921100,00 %